Search Tag: Sepsis Detection

ICU Management


2017 28 May

Healthcare providers are increasingly turning to technology to detect sepsis and report on sepsis management. As most electronic medical record (EMR) providers do not offer easily deployed sepsis modules, healthcare providers report using solutions from infection control and surveillance vendors as well as specialised sepsis solutions. KLAS Research’s...Read more

ICU Management


2017 12 Jun

Sepsis, a life-threatening condition, is difficult to identify accurately in children. Researchers in the U.S. have developed a two-stage electronic sepsis alert (ESA) to improve detection of paediatric severe sepsis in the emergency department. Using a combination of vital signs, risk factors and physician judgment, the ESA reduces missed sepsis diagnoses...Read more

ICU Management


2018 26 Feb

Sutter Solano Medical Center, in collaboration with Cheetah Medical, a Massachusetts-based leader in non-invasive fluid management technology, today announced the presentation of new study results at the Society of Critical Care Medicine’s 47th Annual Critical Care Congress in San Antonio, Texas. These findings demonstrate that the use of improved sepsis...Read more

ICU Management


2019 25 Jul

Existing biomarkers provide limited use for rapid detection of sepsis since they cannot accurately distinguish sepsis from other common conditions encountered in the emergency department (ED). Now a U.S. clinical trial suggests that the monocyte distribution width (MDW) can be a useful indicator of Sepsis-2 and Sepsis-3 in high-risk ED patients. "Changes...Read more

ICU Management


2020 18 Feb

Sepsis continues to be a leading cause of death in hospitalised patients. Approximately 1.7 million individuals develop sepsis each year in the US and of these, around 270,000 die from the infection. Sepsis affects nearly 30 million patients worldwide and nearly 6 million die from sepsis each year. Billions of dollars are required to manage sepsis,...Read more



2022 21 Apr

Based in Switzerland, Abionic is an in vitro diagnostic company, uniquely positioned at the intersection of medical technology, biotechnology and nanotechnology. The company has developed an unparalleled nanofluidic technology-based platform, the abioSCOPE® to offer patients fast blood test results right at the Point-of-Care (PoC). The abioSCOPE® is...Read more



2022 17 May

Sepsis is a heterogeneous syndrome. It has varying characteristics and therapeutic items depending on the patient’s background, socio-economic status, geographic reason, causative pathogens, site of infection, host responses and quality of care. This heterogeneity makes the management of sepsis even more challenging and hinders clinical research planning....Read more



2022 10 Jun

Sepsis is a condition commonly encountered in critically ill patients. However, the management of sepsis varies globally and mainly depends on the availability of resources. Sepsis-related mortality tends to be higher in countries with limited resources.  In this study, the researchers summarise evidence regarding sepsis protocols and their compliances...Read more



2022 09 Aug

BSI certification agency has granted Abionic’s abioSCOPE® device and PSP test the IVDR certification for in-vitro diagnostics. This certification complies with Europe’s new In-vitro Diagnostic Regulation (IVDR), and will be required for products sold within the EU from May 2022 onward. A transitional regulation allows established, non-IVDR-certified...Read more

ICU Management


2023 13 Oct

The use of Artificial Intelligence in detecting sepsis, AI prediction/detection models and how these healthcare tools need to complement clinical expertise.     The potential of Artificial Intelligence (AI) in healthcare has generated significant excitement and discussion. However, it's important to distinguish between the theoretical...Read more